Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells

Development (Cambridge)

Volumn 140, Issue 7, 2013, Pages 1397-1401

  Lee, Heather J ^a   Gallego Ortega, David ^a   Ledger, Anita ^a   Schramek, Daniel ^b   Joshi, Purna ^c   Szwarc, Maria M ^d   Cho, Christina ^a   Lydon, John P ^d   Khokha, Rama ^c   Penninger, Josef M ^b   Ormandy, Christopher J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c UNIVERSITY OF TORONTO   (Canada)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Elf5; Mammary tissue; Mouse; Progesterone; RANKL

Indexed keywords

BETA3 INTEGRIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN; PROTEIN ELF5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CELL; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL EXPANSION; CELL MATURATION; CONTROLLED STUDY; LUNG ALVEOLUS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SECRETORY CELL; STEM CELL;

ANIMALS; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; PROGESTERONE; RANK LIGAND; RECEPTORS, PROGESTERONE; STEM CELLS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84875079780     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.088948     Document Type: Article

References (18)

1. Asselin-Labat, M. L., Sutherland, K. D., Barker, H., Thomas, R., Shackleton, M., Forrest, N. C., Hartley, L., Robb, L., Grosveld, F. G., van der Wees, J. et al. (2007). Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 9, 201-209.
2. Asselin-Labat, M. L., Vaillant, F., Sheridan, J. M., Pal, B., Wu, D., Simpson, E.R., Yasuda, H., Smyth, G. K., Martin, T. J., Lindeman, G. J. et al. (2010).Control of mammary stem cell function by steroid hormone signalling. Nature 465, 798-802.
3. Chakrabarti, R., Hwang, J., Andres Blanco, M., Wei, Y., Lukačišin, M., Romano, R. A., Smalley, K., Liu, S., Yang, Q., Ibrahim, T. et al. (2012a). Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2. Nat. Cell Biol. 14, 1212-1222.
4. Chakrabarti, R., Wei, Y., Romano, R. A., DeCoste, C., Kang, Y. and Sinha, S. (2012b). Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. Stem Cells 30, 1496-1508.
5. Choi, Y. S., Chakrabarti, R., Escamilla-Hernandez, R. and Sinha, S. (2009). Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. Dev. Biol. 329, 227-241.
6. Clarke, R. B. (2003). Steroid receptors and proliferation in the human breast. Steroids 68, 789-794.
7. Fernandez-Valdivia, R., Mukherjee, A., Ying, Y., Li, J., Paquet, M., DeMayo, F.J. and Lydon, J. P. (2009). The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse. Dev. Biol. 328, 127-139.
8. Gonzalez-Suarez, E., Jacob, A. P., Jones, J., Miller, R., Roudier-Meyer, M. P., Erwert, R., Pinkas, J., Branstetter, D. and Dougall, W. C. (2010). RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 468, 103-107.
9. Harris, J., Stanford, P. M., Sutherland, K., Oakes, S. R., Naylor, M. J., Robertson, F. G., Blazek, K. D., Kazlauskas, M., Hilton, H. N., Wittlin, S.X. et al. (2006). Socs2 and elf5 mediate prolactin-induced mammary gland development. Mol. Endocrinol. 20, 1177-1187.
10. Joshi, P. A., Jackson, H. W., Beristain, A. G., Di Grappa, M. A., Mote, P. A., Clarke, C. L., Stingl, J., Waterhouse, P. D. and Khokha, R. (2010). Progesterone induces adult mammary stem cell expansion. Nature 465, 803-807.
11. Kalyuga, M., Gallego-Ortega, D., Lee, H. J., Roden, D. L., Cowley, M. J., Caldon, C. E., Stone, A., Allerdice, S. L., Valdes-Mora, F., Launchbury, R. et al. (2012). ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer. PLoS Biol. 10, e1001461.
12. Lee, H. J. and Ormandy, C. J. (2012). Elf5, hormones and cell fate. Trends Endocrinol. Metab. 23, 292-298.
13. Lydon, J. P., DeMayo, F. J., Funk, C. R., Mani, S. K., Hughes, A. R., Montgomery, C. A., Jr, Shyamala, G., Conneely, O. M. and O'Malley, B.W.(1995). Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9, 2266-2278.
14. Oakes, S. R., Naylor, M. J., Asselin-Labat, M. L., Blazek, K. D., Gardiner- Garden, M., Hilton, H. N., Kazlauskas, M., Pritchard, M. A., Chodosh, L. A., Pfeffer, P. L. et al. (2008). The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes Dev. 22, 581-586.
15. Ormandy, C. J., Camus, A., Barra, J., Damotte, D., Lucas, B., Buteau, H., Edery, M., Brousse, N., Babinet, C., Binart, N. et al. (1997). Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11, 167-178.
16. Schramek, D., Leibbrand, A., Sigl, V., Kenner, L., Hanada, R., Joshi, P., Pospisilik, A., Lee, H. J., Aliprantis, A., Kiechl, S. et al. (2010). Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 468, 98-102.
17. Shackleton, M., Vaillant, F., Simpson, K. J., Stingl, J., Smyth, G. K., Asselin- Labat, M. L., Wu, L., Lindeman, G. J. and Visvader, J. E. (2006). Generation of a functional mammary gland from a single stem cell. Nature 439, 84-88.
18. Travis, R. C. and Key, T. J. (2003). Oestrogen exposure and breast cancer risk. Breast Cancer Res. 5, 239-247.